New: NCI-funded clinical trial search
Mednet Logo

What is your endoscopic approach to the management of refractory GAVE in persistently anemic patients?

1 Answer
Mednet MemberInvited Expert
Hepatology · UC San Diego Health
Answered on

Approaches that I use:

  • Reduce PPI use if able. There is some data that PPIs may make GAVE/DAVE and PHG worse and on occasion, stopping PPI has improved the overall appearance.
  • Some positive data regarding the use of beta blockers for GAVE, although not that great.
  • Depending on the definition of refractory, in this case, APC or even banding if there is a nodular component to it. Even without a nodular component, if there are areas of more severity, then banding can be effective.

Join for free or sign in to see the full answer